A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development
Abstract Malaria continues to be a pressing global health issue, causing nearly half a million deaths per year. An effective malaria vaccine could radically improve our ability to control and eliminate this pathogen. The most advanced malaria vaccine, RTS,S, confers only 30% protective efficacy unde...
Main Authors: | Erwan Atcheson, Adrian V. S. Hill, Arturo Reyes-Sandoval |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-04-01
|
Series: | npj Vaccines |
Online Access: | https://doi.org/10.1038/s41541-021-00302-x |
Similar Items
-
Structure and mechanism of monoclonal antibody binding to the junctional epitope of Plasmodium falciparum circumsporozoite protein.
by: David Oyen, et al.
Published: (2020-03-01) -
Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications.
by: Kavita Gandhi, et al.
Published: (2014-01-01) -
An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein
by: Lucie Jelínková, et al.
Published: (2021-01-01) -
Diversity of T cell epitopes in Plasmodium falciparum circumsporozoite protein likely due to protein-protein interactions.
by: Nagesh R Aragam, et al.
Published: (2013-01-01) -
Correction: Variation in the Circumsporozoite Protein of Plasmodium falciparum: Vaccine Development Implications.
by: Kavita Gandhi, et al.
Published: (2016-01-01)